Paysse E, Lee P P, Lloyd M A, Sidoti P A, Fellenbaum P S, Baerveldt G, Minckler D S, Heuer D K
University of Southern California School of Medicine, Department of Ophthalmology, Doheny Eye Institute, Los Angeles 90033, USA.
J Glaucoma. 1996 Jun;5(3):170-5.
The objective of this study is to identify the rate and the associated risk factors for suprachoroidal hemorrhage (SCH) after Molteno drain implantation.
Data from the Molteno pilot study and single versus double-plate Molteno study were reviewed retrospectively for the occurrence of SCH. Follow-up intervals, demographic variables, ocular data, and medical history were collected.
SCH occurred in 6% of the patients enrolled in the Molteno studies; all cases were delayed and none were intraoperative. Significantly associated factors in a multiple logistic regression for SCH were the extent of intraocular pressure (IOP) drop after surgery, the post-operative IOP, a diagnosis of angleclosure glaucoma, and possibly the number of prior surgeries as well. Eyes with SCH did significantly less well in terms of visual acuity outcomes and were more likely to have inadequately controlled IOP.
This study suggests that SCH occurs at the same frequency after Molteno implantation as after filtering surgery with antimetabolite use and that eyes with SCH do less well.
本研究的目的是确定莫尔顿引流管植入术后脉络膜上腔出血（SCH）的发生率及相关危险因素。
回顾性分析莫尔顿初步研究以及单盘与双盘莫尔顿研究的数据，以确定SCH的发生情况。收集随访间隔、人口统计学变量、眼部数据和病史。
莫尔顿研究中6%的患者发生了SCH；所有病例均为延迟性出血，无术中出血。SCH多因素逻辑回归分析中显著相关的因素包括术后眼压（IOP）下降程度、术后IOP、闭角型青光眼诊断，可能还有既往手术次数。发生SCH的眼在视力预后方面明显较差，且眼压控制不佳的可能性更大。
本研究表明，莫尔顿植入术后SCH的发生率与使用抗代谢药物的滤过性手术后相同，且发生SCH的眼预后较差。
